This panel measures serum copper, plasma zinc, ceruloplasmin, and the copper/zinc ratio — four markers that, together, reveal whether copper toxicity or zinc deficiency is contributing to your anxiety, depression, fatigue, hormonal symptoms, or behavioral issues. Blood testing is not only valid for copper assessment — it is essential.
Copper toxicity is one of the most underdiagnosed drivers of mental health symptoms I see in my practice — particularly in women. The relationship between copper and estrogen means that hormonal events such as puberty, pregnancy, postpartum, oral contraceptive use, and perimenopause can all trigger copper accumulation that destabilizes mood, energy, and cognitive function.
At the same time, zinc deficiency is widespread. We are living in a high-copper world with pervasive zinc depletion due to soil depletion, processed food diets, medications, and stress. The Copper/Zinc Advanced Chemistry Panel is often the hidden biochemical thread that explains symptoms that have resisted every other intervention.
The Three Markers in This Panel
Each marker in this panel serves a distinct purpose. Together, their combined clinical significance gives Samantha the full picture she needs to build your treatment plan.
Serum copper measures the total amount of copper circulating in your blood. This includes copper bound to proteins such as ceruloplasmin and albumin. Serum copper alone is informative, but it should always be evaluated alongside ceruloplasmin to determine how much of that copper is safe versus problematic.
Plasma zinc is the most reliable way to assess zinc status in the blood. I use plasma zinc rather than serum zinc and RBC zinc because plasma is less susceptible to the cellular disruption that can falsely elevate serum and RBC results. Zinc is essential for over 300 enzymatic processes in the body for neurotransmitter production, immune function, gene expression, hormone regulation, and — critically — for keeping copper in check. Zinc and copper compete for absorption. When zinc falls, copper rises.
Ceruloplasmin is the protein responsible for safely binding and transporting approximately 90% of the copper in your bloodstream. Low ceruloplasmin means more copper is circulating in its unbound, free-roaming form — which is highly oxidative. It can then sequester in organs and glands including the liver, brain, thyroid, and adrenal glands, causing chronic oxidative stress. This is what Samantha calls "hidden copper toxicity" — serum copper can appear normal while unbound copper is causing damage at the tissue level.
Why Bloodwork Reveals What Other Tests Cannot
This is the most important concept to understand about copper testing — and it is the reason bloodwork is not just valid, it is irreplaceable.
Copper in the blood exists in two forms. Bound copper is copper attached to proteins such as ceruloplasmin and albumin—safely packaged, doing its job, and not causing harm when within functional ranges. Unbound copper is free-circulating copper that has not been properly packaged. It is highly reactive and oxidative, and when it accumulates, it can deposit in the brain, liver, thyroid, and adrenal glands — driving systemic oxidative stress and the neurological and mood symptoms so many of my clients experience.
Hair testing alone cannot distinguish between these two forms. Only a blood panel that includes ceruloplasmin can calculate the unbound copper fraction — which is why I always use bloodwork as the foundation of copper/zinc assessment, paired with Doctor’s Data Hair Elements for the fuller tissue-level picture.
Copper bound to ceruloplasmin and albumin is safely packaged and performs essential functions throughout the body.
Free-roaming copper not bound to proteins is highly oxidative and can deposit in organs and glands, driving chronic damage.
Addressing the Misinformation
There is a vocal contingent online — that claims blood testing is unreliable for assessing copper status. This position is misleading and has caused real harm by steering people away from testing that reveals critical clinical information.
Some practitioners argue that copper does not show up reliably in blood tests because it is primarily stored in tissues, and that hair analysis is the only accurate way to assess copper status. These claims appear on websites promoting HTMA as a standalone diagnostic tool.
The underlying logic is that serum copper can be "normal" even when tissue copper is elevated — and therefore blood testing misses copper toxicity.
Bloodwork is not inaccurate — it is measuring something different, and more specific, than what hair analysis measures. Only a blood panel can reveal the unbound copper fraction. Serum copper alongside ceruloplasmin allows us to calculate exactly how much copper is circulating unbound and causing oxidative damage — information hair analysis cannot provide at all.
Additionally, the copper/zinc ratio — one of the most clinically significant markers in biochemical psychiatry — requires a blood draw. Dr. Walsh's decades of peer-reviewed research on this ratio is built entirely on blood testing.
What Copper/Zinc Imbalance Drives
Copper and zinc are among the most clinically significant minerals in biochemical psychiatry and functional medicine. An imbalanced ratio between them touches virtually every system in the body — but the brain and nervous system feel it first.
Excess bound and unbound copper directly disrupts dopamine and norepinephrine balance, keeping the sympathetic nervous system in a state of chronic activation. High copper is one of the most common biochemical drivers of treatment-resistant anxiety.
Especially in womenSerum copper rises significantly during pregnancy and does not always normalize postpartum. Dr. Walsh's research found that women with a history of postpartum depression had significantly elevated copper compared to controls. Estrogen stimulates ceruloplasmin production, meaning hormonal shifts drive copper accumulation.
Postpartum and hormonal events75% of young males with ADD, episodic rage, hyperactivity, and assaultive behavior in Dr. Walsh's research exhibited elevated copper/zinc ratios. Copper excess disrupts the catecholamine system, impairing attention, impulse control, and emotional regulation in ways that closely mimic ADHD presentations.
Children and young malesCopper and estrogen have a direct reciprocal relationship — each elevates the other. Women on hormonal contraceptives and the copper IUD, in perimenopause, or with estrogen dominance frequently have elevated copper that worsens with each hormonal fluctuation, driving severe premenstrual mood symptoms, irritability, and fatigue.
Estrogen-copper connectionResearch has found significantly reduced ceruloplasmin and transferrin levels in children with autism, alongside elevated oxidative stress markers. The plasma zinc/serum copper ratio has been identified as a biomarker in children with autism spectrum disorders, with implications for antioxidant capacity and neurological development.
Research-supported connectionWhen unbound copper deposits in the adrenal glands and mitochondria, it disrupts energy production and adrenal function, contributing to the kind of exhaustion that does not respond to rest. Chronic fatigue, fibromyalgia, and adrenal dysfunction are all documented forms of copper-driven oxidative stress.
Adrenal and mitochondrial impactCopper and zinc work together to control the overgrowth of fungal, yeast, and parasitic infections. When the zinc/copper ratio is disturbed, these infections become chronic and are extremely difficult to eliminate regardless of dietary or antifungal interventions — because the underlying mineral imbalance has not been addressed.
Gut-mineral connectionUnbound copper can sequester in the thyroid and adrenal glands, impairing their function even when standard thyroid labs appear normal. This is one of the reasons I often order the copper/zinc panel alongside the full thyroid panel — to understand whether mineral imbalance is contributing to the thyroid picture. Internal link to thyroid test page.
Organ sequestrationThe copper IUD continuously releases copper ions, which can accumulate to toxic levels in susceptible individuals. Oral contraceptives and hormone-based IUDs also elevate estrogen, which stimulates ceruloplasmin production and raises serum copper. Both are important reasons to test the full copper/zinc panel in any woman using or recently removing these contraceptive methods.
Contraceptive copper exposurePublished Research
The clinical significance of copper/zinc imbalance is well-supported by published research. Below are key studies and references that inform how I assess and treat copper and zinc disorders in my practice.
A landmark study finding that 135 assaultive young males (ages 3 to 20) had a median copper/zinc ratio of approximately 1.5 compared to 1.0 in non-violent controls — with elevated serum copper and depressed plasma zinc as the consistent biochemical pattern. This research built the clinical foundation for copper/zinc ratio testing in behavioral health.
Women with prior postpartum depression had significantly higher serum copper levels (approximately 131 micrograms/dL) compared to depressed women without PPD history (approximately 111 micrograms/dL) and non-depressed controls (approximately 106 micrograms/dL). The copper/zinc ratio was also elevated in the PPD group.
This study found significantly reduced serum levels of ceruloplasmin and transferrin — two key antioxidant and metal-binding proteins — in children with autism, alongside increased lipid peroxidation. The findings support oxidative stress as a key mechanism in autism and implicate copper dysregulation as a contributing factor.
This study established the plasma zinc/serum copper ratio as a clinically significant biomarker in children with autism spectrum disorders, linking mineral imbalance to antioxidant capacity and neurological outcomes. It supports the role of copper/zinc testing as a standard part of functional assessment in autism.
An Important Distinction
One of the most common sources of confusion I encounter — both from clients and from other practitioners — is conflating functional copper toxicity with Wilson’s disease. These are completely different conditions, and understanding the distinction is important.
Wilson’s disease is a rare inherited genetic disorder affecting approximately 1 in 30,000 people, in which the body cannot properly excrete copper, leading to severe accumulation in the liver and brain. It is a serious medical condition diagnosed and managed by hepatologists and neurologists.
Functional copper toxicity — what I work with — is far more common and stems from dietary excess, hormonal influences, environmental exposure, zinc deficiency, or impaired detoxification capacity. It is identified through the panel markers covered on this page and addressed through targeted functional nutrition. The two conditions require completely different approaches.
How It Works
This panel is a standard blood draw at your nearest LabCorp location — no special preparation and no kit required. Here is what the process looks like from discovery call to treatment plan.
We spend 20 minutes discussing your symptoms, history, and health goals to determine whether the copper/zinc panel is the right starting point — or whether we should begin with additional tests alongside it.
After sign-up, we complete a full intake session. I order the panel and provide your LabCorp requisition form. If we are also running Hair Elements testing, your Doctor's Data collection kit is mailed to your home separately.
You visit your nearest LabCorp at your convenience for the blood draw — it takes just a few minutes. If you are also completing Hair Elements testing, you follow the kit instructions at home and return it by pre-paid post.
Once all results are in, I build your starting treatment plan. We review your copper/zinc ratio, ceruloplasmin, bound and unbound copper fraction together — then I build your targeted nutrition and supplement protocol. We meet monthly with updates, and you can message me between sessions.
years in practice
Why Work With Samantha
I was trained in the Walsh Institute protocols and have worked with copper and zinc imbalances as a foundational part of my practice for over 20 years. I have seen the same pattern again and again: clients who have spent years in therapy, tried multiple medications, and changed their diet without relief — because the copper/zinc imbalance driving their symptoms was never identified or addressed.
What I offer is not just the panel — it is the interpretation, the context, and the protocol that follows. Knowing your copper/zinc ratio matters far less than knowing what to do with it. That is where 20 years of clinical experience and biochemical training make the difference.
I use both bloodwork and Hair Elements testing together — because a complete copper/zinc assessment requires both. I will advise which combination is right for you based on your symptoms and history.
Common Questions
The panel includes serum copper, plasma zinc, ceruloplasmin, which allow me to calculate your unbound copper and copper/zinc ratio. Together these markers give a complete picture of your copper and zinc balance — including the clinically critical distinction between bound copper (copper attached to proteins) and unbound copper (free-roaming and potentially oxidative). This combination is the standard I use for assessing copper toxicity and zinc deficiency in my practice.
Ceruloplasmin is the protein that carries approximately 90% of the copper in your bloodstream. When ceruloplasmin is low, copper circulates in its unbound form — which is highly reactive and oxidative. Unbound copper can deposit in the brain, liver, thyroid, and adrenal glands, causing chronic oxidative stress that drives mood disorders, fatigue, and neurological symptoms. Testing ceruloplasmin alongside serum copper allows us to calculate exactly how much of your copper is unbound and causing this kind of damage — a calculation that hair analysis or serum copper alone cannot provide.
No — they are completely different conditions. Wilson’s disease is a rare inherited genetic disorder (affecting approximately 1 in 30,000 people) in which a gene mutation prevents the body from excreting copper properly, causing severe accumulation that requires specialist medical management. Functional copper toxicity — what this panel identifies — is an acquired imbalance stemming from diet, hormones, zinc depletion, environmental exposure, or contraceptive use. It is far more common, frequently undiagnosed, and responds well to targeted nutrition and supplement therapy. If results suggest Wilson’s disease rather than functional toxicity, I will refer you to the appropriate specialist.
The copper/zinc ratio is one of the single most clinically significant numbers this panel produces. Copper and zinc are biological antagonists — they compete for absorption and regulate each other’s activity throughout the body. When copper is elevated relative to zinc, the effects are broad: disrupted neurotransmitter production, impaired immune function, elevated oxidative stress, hormonal dysregulation, and increased susceptibility to gut infections. Dr. Walsh’s research found elevated ratios in 75% of young males with assaultive behavior and ADD, and significantly elevated ratios in women with postpartum depression — making it one of the most evidence-supported biomarkers in nutritional psychiatry.
I do not take insurance or provide superbills, but some components of this panel — particularly serum copper and ceruloplasmin — may be partially covered, depending on your plan and the reason for testing. Plasma zinc is less commonly covered. You may be able to submit your service receipt to your insurance company for partial reimbursement. During your discovery call I can walk you through current pricing and which elements are most likely to be covered. I will always advise on the most cost-effective approach to getting you the information we need.
Yes — and there is an important reason to be clear about this. Some people claim that blood testing is inaccurate for copper, which is misleading. Blood testing — specifically a panel that includes ceruloplasmin alongside serum copper — is the only method that allows us to calculate the unbound (free) copper fraction, which is the most clinically significant measure of copper toxicity. Dr. Walsh’s decades of published peer-reviewed research is built on blood testing. Hair analysis provides a different and complementary picture at the tissue level, but it cannot replace what the blood panel reveals.
For a complete copper/zinc assessment, I recommend pairing bloodwork with Doctor’s Data Hair Elements testing — which is why I call hair analysis a “half analysis” on its own. Bloodwork gives us the real-time blood picture, including the unbound copper fraction and the copper/zinc ratio. Hair Elements testing from Doctor’s Data gives us a longer-term picture of mineral status at the tissue level, along with other heavy metals and minerals that blood testing does not cover as comprehensively. Used together, they provide the most accurate and actionable clinical picture. I will advise during your consultation which combination makes sense as your starting point.
Copper and estrogen have a direct reciprocal relationship — each stimulates the other. Estrogen stimulates ceruloplasmin production, and raises total serum copper. This means any hormonal event — puberty, pregnancy, postpartum, oral and IUD contraceptive use, or perimenopause — can trigger a rise in copper that does not fully normalize afterward. Dr. Walsh’s research found that copper overload tends to be far more common in women than men, and I frequently see clients with high anxiety, severe PMS, postpartum depression, and chronic fatigue whose copper has never been tested despite years of symptoms.
After your initial consultation, I provide a LabCorp requisition form that you take to your nearest LabCorp patient service center. No appointment is needed at most locations — you simply walk in and the blood draw takes a few minutes. The sample is analyzed and results come back within 1 to 2 weeks. If we are also running Hair Elements testing, your Doctor’s Data collection kit will be mailed to your home separately, with instructions for collection and return by pre-paid post.
Yes. I work with international clients regularly. The blood draw needs to happen at a LabCorp location in the United States. Canadian clients and others near the border can arrange to cross for the draw, or set up a US address for any kit-based components. I have several clients in Vancouver, BC who manage this routinely. Reach out during your discovery call and we will find the right solution for your location.
Schedule your free 20-minute discovery call with Samantha. We will talk through your symptoms, your history, and whether the Copper/Zinc Advanced Chemistry Panel is the right next step for you.